Research Article
BibTex RIS Cite

CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?

Year 2021, Volume: 23 Issue: 3, 422 - 426, 31.12.2021
https://doi.org/10.24938/kutfd.857325

Abstract

Objective: Numerous articles have been written on macrosomic fetuses, including the American College of Obstetricians and Gynecologists practice bulletin. However, there is no clear consensus about the time of birth. The aim of this study was to compare the maternal and fetal outcomes of women giving birth at 38+0-38+6 weeks and those with deliveries at ≥39 weeks in pregnancies complicated by fetal macrosomia, and to determine the effect on morbidity and mortality of delivery in the 38th gestational week.
Material and Methods: Data of women and their infants born in Kayseri Training and Research Hospital between 01 May 2018 and 31 March 2020 were analyzed retrospectively. The patients included were those with a singleton pregnancy delivered at ≥38 weeks with a birthweight of ≥4000 gr. Demographic data and medical history and birth outcomes of the patients were recorded from the hospital data system. Multiple pregnancies, those with fetal anomalies and births <38 weeks were excluded from the study. The patients were separated into two groups as those who gave birth at 38+0-38+6 gestational weeks (Group 1) and those who gave birth at ≥39 weeks (Group 2).
Results: Maternal and/or fetal trauma was found to be statistically significantly higher in nulliparous women with vaginal delivery ≥39 weeks compared to those with vaginal delivery at 38+0-38+6 weeks (p=0.017). No significant difference was observed between the groups in respect of fetal morbidity and mortality.
Conclusion: When fetal macrosomia is determined antenatally, rates of fetal and/or maternal trauma can be reduced with delivery planned for the 38th week without increasing fetal morbidity and mortality. 

Supporting Institution

None

Project Number

None

Thanks

None

References

  • 1. Macrosomia: ACOG Practice Bulletin, Number 216. Obstet Gynecol. 2020;135(1):18-35.
  • 2. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 173: Fetal Macrosomia. Obstet Gynecol. 2016;128(5):195-209.
  • 3. Chauhan SP, Grobman WA, Gherman RA, Chauhan VB, Chang G, Magann EF et al. Suspicion and treatment of the macrosomic fetus: a review. Am J Obstet Gynecol. 2005;193:332-46.
  • 4. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: Final Data for 2017. Natl Vital Stat Rep. 2018;67(8):1-50.
  • 5. Li G, Kong L, Li Z, Zhang L, Fan L, Zou L et al. Prevalence of macrosomia and its risk Factors in China: A multicentre survey based on birth data involving 101 723 singleton term infants. Paediatr Perinat Epidemiol. 2014;28(4):345-50.
  • 6. Koyanagi A, Zhang J, Dagvadorj A, Hirayama F, Shibuya K, Souza JP et al. Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet. 2013;381(9665):476-83.
  • 7. Zhu Y, Olsen SF, Mendola P, Yeung EH, Vaag A, Bowers K et al. Growth and obesity through the first 7 y of life in association with levels of maternal glycemia during pregnancy: a prospective cohort study. Am J Clin Nutr. 2016;103(3):794-800.
  • 8. Glodean DM, Miclea D, Popa AR. Macrosomia. A systematic review of recent literature. Rom J Diabetes Nutr Metab Dis. 2018;25(2):187-95.
  • 9. Araujo Júnior E, Peixoto AB, Zamarian ACP, Elito Júnior J, Tonni G. Macrosomia. Best Pract Res Clin Obstet Gynaecol. 2017;38:83-96.
  • 10. Stotland NE, Caughey AB, Breed EM, Escobar GJ. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet. 2004;87(3):220-6.
  • 11. Sinkey RG, Blanchard CT, Szychowski JM, Ausbeck E, Subramaniam A, Neely CL et al. Elective induction of labor in the 39th week of gestation compared with expectant management of low-risk multiparous women. Obstet Gynecol. 2019;134(2):282-7.
  • 12. Sancetta R, Khanzada H, Leante R. Shoulder shrug maneuver to facilitate delivery during shoulder dystocia. Obstet Gynecol. 2019;133(6):1178–81.

Makrozomik Fetuslar 38. Gebelik Haftasında Doğurtulabilir Mi?

Year 2021, Volume: 23 Issue: 3, 422 - 426, 31.12.2021
https://doi.org/10.24938/kutfd.857325

Abstract

Amaç: Makrozomik fetüsler hakkında, Amerikan Obstetrik ve Jinekoloji Derneğinin bültenleri de dahil olmak üzere çok sayıda makale yazılmıştır. Ancak doğum zamanı konusunda net bir fikir birliği yoktur. Bu çalışmanın amacı fetal makrozomi ile komplike gebeliklerde 38+0-38+6 hafta arasında doğum yapan kadınlar ile ≥39 hafta sonrasında doğum yapan kadınların maternal ve fetal sonuçlarını karşılaştırmak ve doğum haftasının 38. haftaya çekilmesinin yenidoğanın morbidite ve mortalitesini etkileme düzeyini belirlemektir.
Gereç ve Yöntemler: Bu retrospektif çalışmada, 01 Mayıs 2018-31 Mart 2020 tarihleri arasında Kayseri Eğitim ve Araştırma Hastanesinde doğum yapan kadınların ve bebeklerinin verileri geriye dönük olarak tarandı. Doğum ağırlığı ≥4000 gram, tekil, ≥38 hafta üzerinde doğum yapan hastalar çalışmaya dâhil edildi. Hastaların demografik ve medikal öyküleri ve doğum sonuçları hastane veri sisteminden kayıt edildi. Çoğul gebelikler, fetal anomaliler ve <38 gebelik haftasındaki doğumlar çalışma haricinde tutuldu. Hastalar 38+0- 38+6 hafta arasında doğum yapanlar (Grup 1) ve ≥39 haftada doğum yapanlar (Grup 2) olarak iki gruba ayrıldı.
Bulgular: ≥39 haftadan sonra vajinal doğum yapan (grup 2) nullipar kadınlarda maternal veya fetal travma 38+0 - 38+6 (grup 1) hafta arasında vajinal doğum yapan nullipar kadınlara oranla istatistiksel anlamlı olarak yüksek bulundu (p=0.017). İki grup arasında fetal morbidite ve mortalite incelendiğinde gruplar arasında anlamlı farklılık izlenmedi.
Sonuç: Doğum öncesi değerlendirmede fetal makrozomi saptanan gebelerde fetal ve/veya maternal travma oranları, fetal morbidite ve mortalite arttırılmadan 38. haftada planlanacak bir doğum ile azaltılabilir.

Project Number

None

References

  • 1. Macrosomia: ACOG Practice Bulletin, Number 216. Obstet Gynecol. 2020;135(1):18-35.
  • 2. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 173: Fetal Macrosomia. Obstet Gynecol. 2016;128(5):195-209.
  • 3. Chauhan SP, Grobman WA, Gherman RA, Chauhan VB, Chang G, Magann EF et al. Suspicion and treatment of the macrosomic fetus: a review. Am J Obstet Gynecol. 2005;193:332-46.
  • 4. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: Final Data for 2017. Natl Vital Stat Rep. 2018;67(8):1-50.
  • 5. Li G, Kong L, Li Z, Zhang L, Fan L, Zou L et al. Prevalence of macrosomia and its risk Factors in China: A multicentre survey based on birth data involving 101 723 singleton term infants. Paediatr Perinat Epidemiol. 2014;28(4):345-50.
  • 6. Koyanagi A, Zhang J, Dagvadorj A, Hirayama F, Shibuya K, Souza JP et al. Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet. 2013;381(9665):476-83.
  • 7. Zhu Y, Olsen SF, Mendola P, Yeung EH, Vaag A, Bowers K et al. Growth and obesity through the first 7 y of life in association with levels of maternal glycemia during pregnancy: a prospective cohort study. Am J Clin Nutr. 2016;103(3):794-800.
  • 8. Glodean DM, Miclea D, Popa AR. Macrosomia. A systematic review of recent literature. Rom J Diabetes Nutr Metab Dis. 2018;25(2):187-95.
  • 9. Araujo Júnior E, Peixoto AB, Zamarian ACP, Elito Júnior J, Tonni G. Macrosomia. Best Pract Res Clin Obstet Gynaecol. 2017;38:83-96.
  • 10. Stotland NE, Caughey AB, Breed EM, Escobar GJ. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet. 2004;87(3):220-6.
  • 11. Sinkey RG, Blanchard CT, Szychowski JM, Ausbeck E, Subramaniam A, Neely CL et al. Elective induction of labor in the 39th week of gestation compared with expectant management of low-risk multiparous women. Obstet Gynecol. 2019;134(2):282-7.
  • 12. Sancetta R, Khanzada H, Leante R. Shoulder shrug maneuver to facilitate delivery during shoulder dystocia. Obstet Gynecol. 2019;133(6):1178–81.
There are 12 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Articles
Authors

Ayça Nazlı Bulut 0000-0002-7495-5470

Venhar Ceyhan This is me 0000-0002-8241-9053

Mustafa Bertan Demir 0000-0002-9024-7183

Mehmet Ak 0000-0003-3384-0586

Emine Aydın 0000-0001-8877-2803

Mehmet Dolanbay This is me 0000-0002-8332-1568

Project Number None
Publication Date December 31, 2021
Submission Date January 9, 2021
Published in Issue Year 2021 Volume: 23 Issue: 3

Cite

APA Bulut, A. N., Ceyhan, V., Demir, M. B., Ak, M., et al. (2021). CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, 23(3), 422-426. https://doi.org/10.24938/kutfd.857325
AMA Bulut AN, Ceyhan V, Demir MB, Ak M, Aydın E, Dolanbay M. CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?. Kırıkkale Uni Med J. December 2021;23(3):422-426. doi:10.24938/kutfd.857325
Chicago Bulut, Ayça Nazlı, Venhar Ceyhan, Mustafa Bertan Demir, Mehmet Ak, Emine Aydın, and Mehmet Dolanbay. “CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?”. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 23, no. 3 (December 2021): 422-26. https://doi.org/10.24938/kutfd.857325.
EndNote Bulut AN, Ceyhan V, Demir MB, Ak M, Aydın E, Dolanbay M (December 1, 2021) CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 23 3 422–426.
IEEE A. N. Bulut, V. Ceyhan, M. B. Demir, M. Ak, E. Aydın, and M. Dolanbay, “CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?”, Kırıkkale Uni Med J, vol. 23, no. 3, pp. 422–426, 2021, doi: 10.24938/kutfd.857325.
ISNAD Bulut, Ayça Nazlı et al. “CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?”. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 23/3 (December 2021), 422-426. https://doi.org/10.24938/kutfd.857325.
JAMA Bulut AN, Ceyhan V, Demir MB, Ak M, Aydın E, Dolanbay M. CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?. Kırıkkale Uni Med J. 2021;23:422–426.
MLA Bulut, Ayça Nazlı et al. “CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?”. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, vol. 23, no. 3, 2021, pp. 422-6, doi:10.24938/kutfd.857325.
Vancouver Bulut AN, Ceyhan V, Demir MB, Ak M, Aydın E, Dolanbay M. CAN MACROSOMIC FETUSES BE DELIVERED AT 38 WEEKS OF GESTATION?. Kırıkkale Uni Med J. 2021;23(3):422-6.

Bu Dergi, Kırıkkale Üniversitesi Tıp Fakültesi Yayınıdır.